Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eli Lilly Japan

Division of Eli Lilly & Co.
www.lilly.co.jp

Latest From Eli Lilly Japan

Asia Executives On The Move: Changes At Pfizer, Lilly, Alexion, Healios

The coming of summer has brought a flurry of executive changes in the Asia-Pacific health sector. Pfizer China's head of R&D is leaving while Lilly and Alexion in Japan have new presidents.

Appointments China

Amgen's KRAS Inhibitor AMG 510 Leans Toward Tumor-Dependent, Not Agnostic, Approach

SVP Elliott Levy said the company hasn't ruled out a tumor-agnostic approach for AMG 510, but Phase I data for the first-in-class drug show a bigger effect in lung cancer – a 50% response rate, so far – than in colorectal cancer patients with a KRAS G12C mutation.

ASCO Cancer

Asia Executives To Watch: AZ Japan President, Takeda GM, NHFPC Officials

The new month brings a flurry of personal moves in pharma’s corporate and regulatory landscape in Asia Pacific. AZ Japan has a new president, Takeda has a new GM for its incubator, and China's top health regulator appoints three high-level officials.

Appointments Asia Pacific

Asia On The Move: Novo Appoints New China GM

Novo Nordisk has promoted a VP from Southeast Asia to lead its China operations, amid a flurry of key executive changes at multinational drug makers in China. Top executive changes are also taking place at Abbvie, Nippon Kayaku and UCB in Japan.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Eli Lilly & Co. Japan KK
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Newton Crenshaw, Pres.
  • Contact Info
  • Eli Lilly Japan
    Phone: (81) 78-242-9000
    Sannomiya Plaza Building, 7-1-5 Isogami-
    Dori
    Chuo-ku, 651-0086
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register